168
Views
0
CrossRef citations to date
0
Altmetric
Review

Sleep electroencephalography as a biomarker in depression

, &
Pages 15-25 | Published online: 29 Apr 2015

References

  • Kupfer DJ, Foster FG. Interval between onset of sleep and rapid-eye-movement sleep as an indicator of depression. Lancet. 1972;2:684–686.
  • Chen CN. Sleep, depression and antidepressants. Br J Psychiatry. 1979;135:385–402.
  • Vogel GW, Thurmond A, Gibbons P, Sloan K, Walker M. REM sleep reduction effects on depression syndromes. Arch Gen Psychiatry. 1975;32:765–777.
  • Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Bethesda, MD: US Department of Health, Education and Welfare, Neurological Information Network; 1968.
  • Iber C, Anoli-Israel S, Chesson A, Quan SF; American Academy of Sleep Medicine. The AASM Manual for the Scoring of Sleep and Associated Events: Rules, Terminology and Technical Specifications. 1st ed. Westchester, IL: American Academy of Sleep Medicine; 2007.
  • Allison T, Van Twyver H. The evolution of sleep. Nat Hist. 1970;79:56–65.
  • Borbély AA. A two process model of sleep regulation. Hum Neurobiol. 1982;1:195–204.
  • Jouvet M, Michel F, Courjon J. Sur un stade d’activité électrique cérebrale rapide a cours du sommeil physiologique [On a stage of rapid cerebral electrical activity in the course of physiological sleep]. C R Seances Soc Biol Fil. 1959;153:1024–1028. French.
  • Romanowski C, Fenzl F, Flachskamm C, Deussing JM, Kimura F. CRH-R1 is involved in effects of CRH on NREM, but not REM, sleep suppression. Sleep Biol Rhythms. 2007;5(Suppl 1):A53.
  • Jakubcakova V, Flachskamm C, Landgraf R, Kimura M. Sleep phenotyping in a mouse model of extreme trait anxiety. PLoS One. 2012;7: e40625.
  • Deboer T. Behavioral and electrophysiological correlates of sleep and sleep homeostasis. In: Current Topics in Behavioral Neurosciences. Geyer MA, Ellenbroek BA, Marsden CA, Barnes TRE, editors. Berlin: Springer; 2013:1–24.
  • Hawkins DR, Taub JM, Van de Castle RL. Extended sleep (hypersomnia) in young depressed patients. Am J Psychiatry. 1985;142:905–910.
  • Armitage R. Sleep and circadian rhythms in mood disorders. Acta Psychiatr Scand. 2007;115(Suppl 433):104–115.
  • Reynolds CF 3rd, Kupfer DJ. Sleep research in affective illness: state of the art circa 1987. Sleep. 1987;10:199–215.
  • Benca RM, Okawa M, Uchiyama M, et al. Sleep and mood disorders. Sleep Med Rev. 1997;1:45–56.
  • Lauer C, Riemann D, Wiegand M, Berger M. From early to late adulthood. Changes in EEG sleep of depressed patients and healthy volunteers. Biol Psychiatry. 1991;29:979–993.
  • Riemann D, Hohagen F, Lauer C, Berger M. Longterm evolution of sleep in depression. In: Smirne S, Franceschi M, Ferini-Strambi L, editors. Sleep and Aging. Paris: Masson; 1991:195–204.
  • Schulz H, Lund R, Cording C, Dirlich G. Bimodal distribution of REM sleep latencies in depression. Biol Psychiatry. 1979;14:595–600.
  • Ansseau M, Kupfer DJ, Reynolds CF 3rd, McEachran AB. REM latency distribution in major depression: clinical characteristics associated with sleep onset REM periods. Biol Psychiatry. 1984: 1651–1666.
  • Kupfer DJ, Reynolds CF 3rd, Grochocinski VJ, Ulrich RF, McEachran A. Aspects of short REM latency in affective states: a revisit. Psychiatry Res. 1986;17:49–59.
  • Gillin JC, Sitaram N, Wehr T, et al. Sleep and affective illness. In: Post RM, Ballenger JC, editors. Neurobiology of Mood Disorders. Baltimore: Williams and Wilins; 1984;157–189.
  • Schulz H, Lund R, Doerr P. The measurement of change in sleep during depression and remission. Arch Psychiatr Nervenkr. 1978;225:233–245.
  • Coble PA, Kupfer DJ, Spiker DG, Neil JF, McPartland RJ. EEG sleep in primary depression. A longitudinal placebo study. J Affect Disord. 1979;1:131–138.
  • Rush AJ, Erman MK, Giles DE, et al. Polysomnographic findings in recently drug-free and clinically remitted depressed patients. Arch Gen Psychiatry. 1986;43:878–884.
  • Steiger A, von Bardeleben U, Herth T, Holsboer F. Sleep EEG and nocturnal secretion of cortisol and growth hormone in male patients with endogenous depression before treatment and after recovery. J Affect Disord. 1989;16:189–195.
  • Rao U, Poland RE. Electroencephalographic sleep and hypothalamic-pituitary-adrenal changes from episode to recovery in depressed adolescents. J Child Adolesc Psychopharmacol. 2008;18:607–613.
  • Kupfer DJ, Foster FG, Reich L, Thompson SK, Weiss B. EEG sleep changes as predictors in depression. Am J Psychiatry. 1976;133:622–626.
  • Spiker DG, Coble P, Cofsky J, Foster FG, Kupfer DJ. EEG sleep and severity of depression. Biol Psychiatry. 1978;13:485–488.
  • Feinberg M, Gillin JC, Carroll BJ, Greden JF, Zis AP. EEG studies of sleep in the diagnosis of depression. Biol Psychiatry. 1982;17:305–316.
  • Taub JM, Hawkins DR, Van de Castle RL. Electrographic analysis of the sleep cycle in young depressed patients. Biol Psychol. 1978;7:203–214.
  • Puig-Antich J, Goetz R, Hanlon C, et al. Sleep architecture and REM sleep measures in prepubertal children with major depression: a controlled study. Arch Gen Psychiatry. 1982;39:932–939.
  • Goetz RR, Puig-Antich J, Ryan N, et al. Electroencephalographic sleep of adolescents with major depression and normal controls. Arch Gen Psychiatry. 1987;44:61–68.
  • Kupfer DJ, Coble P, Kane J, Petti T, Conners CK. Imipramine and EEG sleep in children with depressive symptoms. Psychopharmacology (Berl). 1979;60:117–123.
  • Lahmeyer HW, Poznanski EO, Bellur SN. EEG sleep in depressed adolescents. Am J Psychiatry. 1983;140:1150–1153.
  • Hudson JI, Lipinski JF, Frankenburg FR, Grochocinski VJ, Kupfer DJ. Electroencephalographic sleep in mania. Arch Gen Psychiatry. 1988; 45:267–273.
  • Zarcone VP Jr, Benson KL, Berger PA. Abnormal rapid eye movement latencies in schizophrenia. Arch Gen Psychiatry. 1987;44:45–48.
  • Reich L, Weiss BL, Coble P, McPartland R, Kupfer DJ. Sleep disturbance in schizophrenia. A revisit. Arch Gen Psychiatry. 1975;32:51–55.
  • Uhde TW, Roy-Byrne P, Gillin JC, et al. The sleep of patients with panic disorder: a preliminary report. Psychiatry Res. 1984;12:251–259.
  • Katz JL, Kuperberg A, Pollack CP, Walsh BT, Zumoff B, Weiner H. Is there a relationship between eating disorder and affective disorder? New evidence from sleep recordings. Am J Psychiatry. 1984;141:753–759.
  • Insel TR, Gillin C, Moore A, Wallace BM, Loewenstein RJ, Murphy DL. The sleep of patients with obsessive-compulsive disorder. Arch Gen Psychiatry. 1982;39:1372–1377.
  • Schmidt HS, Nofzinger EA. Short REM latency in impotence without depression. Biol Psychiatry. 1988;24:25–32.
  • Lauer CJ, Krieg JC, Riemann D, Zulley J, Berger M. A polysomnographic study in young psychiatric inpatients: major depression, anorexia nervosa, bulimia nervosa. J Affect Disord. 1990;18:235–245.
  • Lauer CJ, Krieg JC, Garcia-Borreguero D, Ozdaglar A, Holsboer F. Panic disorder and major depression: a comparative electroencephalogramic sleep study. Psychiatry Res. 1992;44:41–54.
  • Kupfer DJ, Ehlers CL, Frank E, Grochocinski VJ, McEachran AB. EEG sleep profiles and recurrent depression. Biol Psychiatry. 1991;30:641–655.
  • Thase ME, Kupfer DJ, Buysse DJ, et al. Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: I. Comparison during acute depressive states. Biol Psychiatry. 1995;38:506–515.
  • Jindal RD, Thase ME, Fasiczka AL, et al. Electroencephalographic sleep profiles in single-episode and recurrent unipolar forms of major depression: II. Comparison during remission. Biol Psychiatry. 2002;51:230–236.
  • Svendsen K, Christensen PG. Duration of REM sleep latency as predictor of effect of antidepressant therapy. A preliminary report. Acta Psychiatr Scand. 1981;64:238–243.
  • Rush AJ, Giles DE, Jarrett RB, et al. Reduced REM latency predicts response to tricyclic medication in depressed outpatients. Biol Psychiatry. 1989;26:61–72.
  • Heiligenstein JH, Faries DE, Rush AJ, et al. Latency to rapid eye movement sleep as a predictor of treatment response to fluoxetine and placebo in nonpsychotic depressed outpatients. Psychiatry Res. 1994;52:327–339.
  • Thase ME, Simons AD, Reynolds CF 3rd. Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy. Arch Gen Psychiatry. 1996;53:99–108.
  • Thase ME, Kupfer DJ, Fasiczka AJ, Buysse DJ, Simons AD, Frank E. Identifying an abnormal electroencephalographic sleep profile to characterize major depressive disorder. Biol Psychiatry. 1997;41:964–973.
  • Buysse DJ, Tu XM, Cherry CR, et al. Pretreatment REM sleep and subjective sleep quality distinguish depressed psychotherapy remitters and nonremitters. Biol Psychiatry. 1999;45:205–213.
  • Buysse DJ, Hall M, Begley A, et al. Sleep and treatment response in depression: new findings using power spectral analysis. Psychiatry Res. 2001;103:51–67.
  • Lucae S, Salyakina D, Barden N, et al. P2RX7, a gene coding for a purinergic ligand-gated ion channel, is associated with major depressive disorder. Hum Mol Genet. 2006;15:2438–2445.
  • Adamczyk M, Friess E, Uhr M, Steiger A. Sleep-EEG differences in healthy volunteers related to Gln460arg polymorphism of P2RX7 gene. Biol Psychiatry. 2014;75(Suppl):71.
  • Lauer CJ, Schreiber W, Holsboer F, Krieg JC. In quest of identifying vulnerability markers for psychiatric disorders by all-night polysomnography. Arch Gen Psychiatry. 1995;52:145–153.
  • Modell S, Ising M, Holsboer F, Lauer CJ. The Munich Vulnerability Study on Affective Disorders: stability of polysomnographic findings over time. Biol Psychiatry. 2002;52:430–437.
  • Schreiber W, Lauer CJ, Krumrey K, Holsboer F, Krieg JC. Cholinergic REM sleep induction test in subjects at high risk for psychiatric disorders. Biol Psychiatry. 1992;32:79–90.
  • Lauer CJ, Modell S, Schreiber W, Krieg JC, Holsboer F. Prediction of the development of a first major depressive episode with a rapid eye movement sleep induction test using the cholinergic agonist RS 86. J Clin Psychopharmacol. 2004;24:356–357.
  • Modell S, Ising M, Holsboer F, Lauer CJ. The Munich vulnerability study on affective disorders: premorbid polysomnographic profile of affected high-risk probands. Biol Psychiatry. 2005;58:694–699.
  • Dunleavy DL, Brezinova V, Oswald I, MacLean AW, Tinker M. Changes during weeks in effects of tricyclic drugs on the human sleeping brain. Br J Psychiatry. 1972;120:663–672.
  • Dunleavy DL, Oswald I. Phenelzine, mood response, and sleep. Arch Gen Psychiatry. 1973;28:353–356.
  • Passouant P, Cadilhac J, Billiard M, Besset A. La suppression du sommeil paradoxal par la clomipramine. Thérapie. 1973;28:379–392. French.
  • Sonntag A, Rothe B, Guldner J, Yassouridis A, Holsboer F, Steiger A. Trimipramine and imipramine exert different effects on the sleep EEG and on nocturnal hormone secretion during treatment of major depression. Depression. 1996;4:1–13.
  • Cramer H, Ohlmeier D. Ein fall von tranylcypromin undtTrifluoperazin – (jatrosom)-sucht: psychopathologische, schlafphysiologische und biochemische Untersuchungen. Arch Psychiatr Nervenkr. 1967;210:182–197. German.
  • Akindele MO, Evans JI, Oswald I. Monoamine oxidase inhibitors, sleep and mood. Electroencephalogr Clin Neurophysiol. 1970;29:47–56.
  • Wyatt RJ, Fram DH, Kupfer DJ, Snyder F. Total prolonged drug-induced REM sleep suppression in anxious depressed patients. Arch Gen Psychiatry. 1971;24:145–155.
  • Cohen RM, Pickar D, Garnett D, Lipper S, Gillin JC, Murphy DL. REM sleep suppression induced by selective monoamine oxidase inhibitors. Psychopharmacology (Berl). 1982;78:137–140.
  • Landolt HP, Raimo EB, Schnierow BJ, Kelsoe JR, Rapaport MH, Gillin JC. Sleep and sleep electroencephalogram in depressed patients treated with phenelzine. Arch Gen Psychiatry. 2001;58:268–276.
  • Steiger A, Benkert O, Holsboer F. Effects of long-term treatment with the MAO-A inhibitor moclobemide on sleep EEG and nocturnal hormonal secretion in normal men. Neuropsychobiology. 1994;30:101–105.
  • Shipley JE, Kupfer DJ, Dealy RS, et al. Differential effects of amitriptyline and of zimelidine on the sleep electroencephalogram of depressed patients. Clin Pharmacol Ther. 1984;36:251–259.
  • von Bardeleben U, Steiger A, Gerken A, Holsboer F. Effects of fluoxetine upon pharmacoendocrine and sleep-EEG parameters in normal controls. Int Clin Psychopharmacol. 1989;4 (Suppl 1):1–5.
  • Künzel HE, Murck H, Held K, Ziegenbein M, Steiger A. Reboxetine induces similar sleep EEG changes like SSRI`s in patients with depression. Pharmacopsychiatry. 2004;37:193–195.
  • Kluge M, Schüssler P, Steiger A. Duloxetine increases stage 3 sleep and suppresses rapid eye movement (REM) sleep in patients with major depression. Eur Neuropsychopharmacol. 2007;17:527–531.
  • Nofzinger EA, Reynolds CF 3rd, Thase ME, et al. REM sleep enhancement by bupropion in depressed men. Am J Psychiatry. 1995;152:274–276.
  • Ruigt GSF, Kemp B, Groenhout CM, Kamphuisen HA. Effect of the antidepressant Org 3770 on human sleep. Eur J Clin Pharmacol. 1990;38:551–554.
  • Aslan S, Isik E, Cosar B. The effects of mirtazapine on sleep: a placebo controlled, double-blind study in young healthy volunteers. Sleep. 2002;25:677–679.
  • Winokur A, DeMartinis NA3rd, McNally DP, Gary EM, Cormier JL, Gary KA. Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry. 2003;64:1224–1229.
  • Schmid DA, Wichniak A, Uhr M, et al. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin and leptin and the DEX-CRH test in depressed patients during treatment with mirtazapine. Neuropsychopharmacology. 2006;31:832–844.
  • Murck H, Nickel T, Künzel H, et al. State markers of depression in sleep EEG: dependency on drug and gender in patients treated with tianeptine or paroxetine. Neuropsychopharmacology. 2003;28:348–358.
  • Steiger A, von Bardeleben U, Guldner J, Lauer C, Rothe B, Holsboer F. The sleep EEG and nocturnal hormonal secretion. Studies on changes during the course of depression and on effects of CNS-active drugs. Prog Neuropsychopharmacol Biol Psychiatry. 1993;17:125–137.
  • Steiger A. Effects of clomipramine on sleep-EEG and nocturnal penile tumescence (NPT), a long-term study in a healthy man. J Clin Psychopharmacol. 1988;8:349–354.
  • Murck H, Frieboes RM, Antonijevic IA, Steiger A. Distinct temporal pattern of the effects of the combined serotonin-reuptake inhibitor and 5-HT1A agonist EMD 68843 on the sleep EEG in healthy men. Psychopharmacology (Berl). 2001;155:187–192.
  • Vogel GW. Evidence for REM sleep deprivation as the mechanism of action of antidepressant drugs. Prog Neuropsychopharmacol Biol Psychiatry. 1983;7:343–349.
  • Gillin JC, Wyatt RJ, Fram D, Snyder F. The relationship between changes in REM sleep and clinical improvement in depressed patients treated with amitriptyline. Psychopharmacology (Berl). 1978;59:267–272.
  • Shipley JE, Kupfer DJ, Griffin SJ, et al. Comparison of effects of desipramine and amitriptyline on EEG sleep of depressed patients. Psychopharmacology (Berl). 1985;85:14–22.
  • Landolt HP, de Boer LP. Effect of chronic phenelzine treatment on REM sleep: report of three patients. Neuropsychopharmacology. 2001;25(Suppl 5):S63–S67.
  • Grözinger M, Kogel P, Röschke J. Effects of REM sleep awakenings and related wakening paradigms on the ultradian sleep cycle and the symptoms in depression. J Psychiatr Res. 2002;36:299–308.
  • Wiegand M, Berger M, Zulley J, von Zerssen D. The effect of trimipramine on sleep in patients with major depressive disorder. Pharmacopsychiatry. 1986;19:198–199.
  • Steiger A, Gerken A, Benkert O, Holsboer F. Differential effects of the enantiomers R(-) and S(+) oxaprotiline on major endogenous depression, the sleep EEG and neuroendocrine secretion: studies on depressed patients and normal controls. Eur Neuropsychopharmacol. 1993;3:117–126.
  • Kupfer DJ, Spiker DG, Rossi A, Coble PA, Shaw D, Ulrich R. Nortriptyline and EEG sleep in depressed patients. Biol Psychiatry. 1982;17:535–546.
  • Saletu B, Frey R, Krupka M, Anderer P, Grunberger J, See WR. Sleep laboratory studies on the single-dose effects of serotonin reuptake inhibitors paroxetine and fluoxetine on human sleep and awakening qualities. Sleep. 1991;14:439–447.
  • Sharpley AL, Williamson DJ, Attenburrow ME, Pearson G, Sargent P, Cowen PJ. The effects of paroxetine and nefazodone on sleep: a placebo controlled trial. Psychopharmacology (Berl). 1996;126:50–54.
  • Kupfer DJ. REM latency: a psychobiologic marker for primary depressive disease. Biol Psychiatry. 1976;11:159–174.
  • Riemann D, Berger M. The effects of total sleep deprivation and subsequent treatment with clomipramine on depressive symptoms and sleep electroencephalography in patients with a major depressive disorder. Acta Psychiatr Scand. 1990;81:24–31.
  • Cook IA, Hunter AM, Gilmer WS, et al. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial. J Clin Psychiatry. 2013;74:51–56.
  • Mulert C, Juckel G, Brunnmeier M, et al. Prediction of treatment response in major depression: integration of concepts. J Affect Disord. 2007;98:215–225.
  • Leuchter AF, Cook IA, Lufkin RB, et al. Cordance: a new method for assessment of cerebral perfusion and metabolism using quantitative electroencephalography. Neuroimage. 1994;1:208–219.
  • Leuchter AF, Uijtdehaage SH, Cook IA, O’Hara R, Mandelkern M. Relationship between brain electrical activity and cortical perfusion in normal subjects. Psychiatry Res. 1999;90:125–140.
  • Bares M, Brunovsky M, Kopecek M, et al. Early reduction in prefrontal theta QEEG cordance value predicts response to venlafaxine treatment in patients with resistant depressive disorder. Eur Psychiatry. 2008;23:350–355.
  • Cook IA, Leuchter AF, Morgan M, et al. Early changes in prefrontal activity characterize clinical responders to antidepressants. Neuropsychopharmacology. 2002;27:120–131.
  • Bares M, Brunovsky M, Novak T, et al. The change of prefrontal QEEG theta cordance as a predictor of response to bupropion treatment in patients who had failed to respond to previous antidepressant treatments. Eur Neuropsychopharmacol. 2010;20:459–466.
  • Cook IA, Leuchter AF, Morgan ML, Stubbeman W, Siegman B, Abrams M. Changes in prefrontal activity characterize clinical response in SSRI nonresponders: a pilot study. J Psychiatr Res. 2005;39:461–466.
  • Cook IA, Hunter AM, Abrams M, Siegman B, Leuchter AF. Midline and right frontal brain function as a physiologic biomarker of remission in major depression. Psychiatry Res. 2009;174:152–157.
  • Kopecek M, Sos P, Brunovsky M, Bares M, Stopkova P, Krajca V. Can prefrontal theta cordance differentiate between depression recovery and dissimulation? Neuro Endocrinol Lett. 2007;28:524–526.
  • Kopecek M, Tislerova B, Sos P, et al. QEEG changes during switch from depression to hypomania/mania: a case report. Neuro Endocrinol Lett. 2008;29:295–302.
  • Pawlowski M, Dresler M, Holsboer F, Steiger A. Cordance as a biomarker in sleep EEG for depression: responders versus nonresponders: a naturalistic study after antidepressant medication. Eur Neuropsychopharmacol. 2011;21:S360–S361.
  • Hatzinger M, Hemmeter UM, Brand S, Ising M, Holsboer-Trachsler E. Electroencephalographic sleep profiles in treatment course and long-term outcome of major depression: association with DEX/CRH-test response. J Psychiatr Res. 2004;38:453–465.
  • Steiger A. Neurochemical regulation of sleep. J Psychiatr Res. 2007;41:537–552.
  • Linkowski P, Mendlewicz J, Kerkhofs M, et al. 24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment. J Clin Endocrinol Metab. 1987;65:141–152.
  • Ehlers CL, Reed TK, Henriksen SJ. Effects of corticotropin-releasing factor and growth hormone-releasing factor on sleep and activity in rats. Neuroendocrinology. 1986;42:467–474.
  • Opp M, Obál F Jr, Krueger JM. Corticotropin-releasing factor attenuates interleukin 1-induced sleep and fever in rabbits. Am J Physiol. 1989;257:R528–R535.
  • Sanford LD, Yang L, Wellman LL, Dong E, Tang X. Mouse strain differences in the effects of corticotropin releasing hormone (CRH) on sleep and wakefulness. Brain Res. 2008;1190:94–104.
  • Holsboer F, von Bardeleben U, Steiger A. Effects of intravenous corticotropin-releasing hormone upon sleep-related growth hormone surge and sleep EEG in man. Neuroendocrinology. 1988;48:32–38.
  • Schüssler P, Kluge M, Dresler M, Yassouridis A, Steiger A. Sleep-impairing effect of intravenous corticotropin-releasing hormone on sleep EEG in young healthy women. Exp Clin Endocrinol Diabetes. 2009;117:664.
  • Antonijevic IA, Steiger A. Depression-like changes of the sleep-EEG during high dose corticosteroid treatment in patients with multiple sclerosis. Psychoneuroendocrinology. 2003;28:780–795.
  • Hatzinger M, Brand S, Perren S, et al. Electroencephalographic sleep profiles and hypothalamic-pituitary-adrenocortical (HPA) activity in kindergarten children: Early indication of poor sleep quality associated with increased cortisol secretion. J Psychiatr Res. 2008;42:532–543.
  • Held K, Künzel H, Ising M, et al. Treatment with the CRH1-receptor antagonist R121919 improves sleep EEG in patients with depression. J Psychiatr Res. 2004;38:129–136.
  • Henn FA, Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci Biobehav Rev. 2005;29:799–804.
  • Adrien J, Dugovic C, Martin P. Sleep-wakefulness patterns in the helpless rat. Physiol Behav. 1991;49:257–262.
  • El Yacoubi M, Bouali S, Popa D, et al. Behavioral, neurochemical, and electrophysiological characterization of a genetic mouse model of depression. Proc Natl Acad Sci U S A. 2003;100:6227–6232.
  • Popa D, El Yacoubi M, Vaugeois JM, Hamon M, Adrien J. Homeostatic regulation of sleep in a genetic model of depression in the mouse: effects of muscarinic and 5-HT1A receptor activation. Neuropsychopharmacology. 2006;31:1637–1646.
  • Dugovic C, Maccari S, Weibel L, Turek FW, Van Reeth O. High corticosterone levels in prenatally stressed rats predict persistent paradoxical sleep alterations. J Neurosci. 1999;19:8656–8664.
  • Dugovic C, Solberg LC, Redei E, Van Reeth O, Turek FW. Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression. Neuroreport. 2000;11:627–631.
  • Steiger A, Kimura M. Wake and sleep EEG provide biomarkers in depression. J Psychiatr Res. 2010;44:242–252.
  • Grønli J, Murison R, Bjørvatn B, Sørensen E, Portas CM, Ursin R. Chronic mild stress affects sucrose intake and sleep in rats. Behav Brain Res. 2004;150:139–147.
  • Touma C, Fenzl T, Ruschel J et al. Rhythmicity in mice selected for extremes in stress reactivity: Behavioural, endocrine and sleep changes resembling endophenotypes of major depression. PLoS One. 2009;4:e4325.
  • Fenzl T, Touma C, Romanowski CP, et al. Sleep disturbances in highly stress reactive mice: modeling endophenotypes of major depression. BMC Neurosci. 2011;12:29.
  • Holsboer F, Ising M. Stress hormone regulation: biological role and translation into therapy. Annu Rev Psychol. 2010;61:81–109.
  • Lu A, Steiner MA, Whittle N, et al. Conditional mouse mutants highlight mechanisms of corticotropin-releasing hormone effects on stress-coping behavior. Mol Psychiatry. 2008;13:1028–1042.
  • Kimura M, Müller-Preuss P, Lu A, et al. Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep. Mol Psychiatry. 2010;15:154–165.
  • Curzi ML, Flachskamm C, Deussing JM, Kimura M. Enhanced REM sleep and cholinergic hyperactivity in forebrain-specific CRH-overexpressing mice. J Sleep Res. 2012;21(Suppl 1):192.
  • Shiromani PJ, Overstreet D, Levy D, Goodrich CA, Campbell SS, Gillin JC. Increased REM sleep in rats selectively bred for cholinergic hyperactivity. Neuropsychopharmacology.1988;1:127–133.
  • Overstreet DH, Friedman E, Mathe AA, Yadid G. The Flinders Sensitive Line rat: a selectively bred putative animal model of depression. Neurosci Biobehav Rev. 2005;29:739–759.
  • Berger M, Höchli D, Zulley J, Lauer C, von Zerssen D. Cholinomimetic drug RS 86, REM sleep, and depression. Lancet. 1985;1:1385–1386.
  • Grønli J, Fiske E, Murison R, et al. Extracellular levels of serotonin and GABA in the hippocampus after chronic mild stress in rats. A microdialysis study in an animal model of depression. Behav Brain Res. 2007;181:42–51.
  • Novati A, Roman V, Cetin T, et al. Chronically restricted sleep leads to depression-like changes in neurotransmitter receptor sensitivity and neuroendocrine stress reactivity in rats. Sleep. 2008;31:1579–1585.
  • Mrdalj J, Pallesen S, Milde AM, et al. Early and later life stress alter brain activity and sleep in rats. PLoS One. 2013;8:e69923.
  • Steiger A. Neuroendocrinology of sleep disorders. In: D’haenen D, den Boer JA, Westenberg H, Willner P, editors. Textbook of Biological Psychiatry. London: John Wiley and Sons, Ltd; 2002:1229–1246.